Polycystic Kidney Disease: A Disorder Out of Time?
作者信息
Braun Fabian, Müller Roman-Ulrich
机构信息
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
出版信息
J Am Soc Nephrol. 2025 Mar 1;36(3):331-332. doi: 10.1681/ASN.0000000617. Epub 2025 Jan 21.
Abstract
摘要
相似文献
1
Polycystic Kidney Disease: A Disorder Out of Time?多囊肾病：一种不合时宜的疾病？
J Am Soc Nephrol. 2025 Mar 1;36(3):331-332. doi: 10.1681/ASN.0000000617. Epub 2025 Jan 21.
3
Initial Suspicion of Autosomal Dominant Polycystic Kidney Disease Resulted in a Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease Caused by a UMOD Mutation: A Case Report.最初怀疑为常染色体显性遗传性多囊肾病，最终诊断为由UMOD突变引起的常染色体显性遗传性肾小管间质性肾病：一例报告
Intern Med. 2025 Jun 19. doi: 10.2169/internalmedicine.5563-25.
4
Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials.生长抑素类似物治疗多囊肾病和肝病进展的效果：系统评价和随机临床试验荟萃分析。
PLoS One. 2021 Sep 24;16(9):e0257606. doi: 10.1371/journal.pone.0257606. eCollection 2021.
5
The Risk for New-Onset Diabetes Mellitus after Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.常染色体显性遗传多囊肾病患者肾移植后新发糖尿病的风险：系统评价和荟萃分析。
Can J Diabetes. 2016 Dec;40(6):521-528. doi: 10.1016/j.jcjd.2016.03.001. Epub 2016 May 13.
6
Intestinal barrier function declines during polycystic kidney disease progression.在多囊肾病进展过程中，肠道屏障功能会下降。
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F218-F229. doi: 10.1152/ajprenal.00058.2024. Epub 2024 Dec 18.
7
Physiologic mechanisms underlying polycystic kidney disease.多囊肾病的生理机制。
Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12.
8
Staged versus concurrent native nephrectomy and renal transplantation in patients with autosomal dominant polycystic kidney disease: A systematic review.分阶段与同期自体显性多囊肾病患者的肾切除术和肾移植术：系统评价。
Transplant Rev (Orlando). 2022 Jan;36(1):100652. doi: 10.1016/j.trre.2021.100652. Epub 2021 Sep 16.
9
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group.常染色体显性多囊肾病的肾切除术：欧洲肾脏协会基因与肾脏工作组的共识声明
Nephrol Dial Transplant. 2025 Apr 28;40(5):1032-1054. doi: 10.1093/ndt/gfaf019.
10
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.母体肥胖对小鼠模型中多囊肾病进展的影响。
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.
本文引用的文献
1
The glomerular circadian clock temporally regulates basement membrane dynamics and the podocyte glucocorticoid response.肾小球昼夜节律钟在时间上调节基底膜动力学和足细胞糖皮质激素反应。
Kidney Int. 2025 Jan;107(1):99-115. doi: 10.1016/j.kint.2024.10.016. Epub 2024 Nov 6.
2
Circadian Clock Disruption and Growth of Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease.昼夜节律紊乱与常染色体显性多囊肾病中肾囊肿的生长
J Am Soc Nephrol. 2025 Mar 1;36(3):378-392. doi: 10.1681/ASN.0000000528. Epub 2024 Oct 14.
3
How Does ADPKD Severity Differ Between Family Members?常染色体显性多囊肾病在家庭成员之间的严重程度如何不同？
Kidney Int Rep. 2024 Feb 5;9(5):1198-1209. doi: 10.1016/j.ekir.2024.01.053. eCollection 2024 May.
4
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial.生酮饮食干预多囊肾病的可行性和影响：KETO-ADPKD-一项随机对照试验。
Cell Rep Med. 2023 Nov 21;4(11):101283. doi: 10.1016/j.xcrm.2023.101283. Epub 2023 Nov 7.
5
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.托伐普坦治疗常染色体显性遗传性多囊肾病的应用进展：代表欧洲肾脏协会遗传性肾脏疾病工作组、欧洲罕见肾脏疾病参考网络和多囊肾病国际组织的共识声明。
Nephrol Dial Transplant. 2022 Apr 25;37(5):825-839. doi: 10.1093/ndt/gfab312.
6
Metabolic rivalry: circadian homeostasis and tumorigenesis.代谢竞争：昼夜节律内稳态与肿瘤发生。
Nat Rev Cancer. 2020 Nov;20(11):645-661. doi: 10.1038/s41568-020-0291-9. Epub 2020 Sep 7.
7
Metabolic reprogramming and the role of mitochondria in polycystic kidney disease.代谢重编程及线粒体在多囊肾病中的作用。
Cell Signal. 2020 Mar;67:109495. doi: 10.1016/j.cellsig.2019.109495. Epub 2019 Dec 6.
8
Circadian rhythms and the kidney.昼夜节律与肾脏。
Nat Rev Nephrol. 2018 Oct;14(10):626-635. doi: 10.1038/s41581-018-0048-9.
9
2-Deoxy-d-Glucose Ameliorates PKD Progression.2-脱氧-D-葡萄糖可改善多囊肾病的进展。
J Am Soc Nephrol. 2016 Jul;27(7):1958-69. doi: 10.1681/ASN.2015030231. Epub 2015 Nov 3.
10
Sex differences in circadian timing systems: implications for disease.昼夜节律系统中的性别差异：对疾病的影响。
Front Neuroendocrinol. 2014 Jan;35(1):111-39. doi: 10.1016/j.yfrne.2013.11.003. Epub 2013 Nov 25.
Zotero 插件